Abstract B060: Sociodemographic and geographic disparities in NCCN-concordant first-line systemic therapy in metastatic breast cancer, 2014–2022: The PRISM Study
Despite established NCCN guidelines, disparities in guideline-concordant care persist in metastatic breast cancer (mBC). We examined first-line Category 1 systemic therapy concordance and time to treatment to characterize equity gaps at an academic medical center. In the PRISM (Precision Oncology Risk Iden...